A closer look

The inventor of insulin sold the original patent for a single dollar because he believed it belonged to humanity. Modern American pharmaceutical conglomerates took that humanitarian dream and turned it into a dystopian cash grab. Through minor 'evergreening' patent tweaks and backroom deals with pharmacy benefit managers, they keep insulin prices artificially sky-high, forcing diabetics to ration a drug that costs under ten dollars to produce.